利润表
ALDEYRA THERAPEUTICS, INC.
ALDX
业绩概览
点击表格中任意一行将其添加到图表
单位：百万美元
| 指标 | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
营业收入
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
营业成本
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
毛利润
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
营业费用
|
35.27 | 60.12 | 42.79 | 62.68 | 56.22 | 34.67 | 56.51 | 39.70 | 22.49 | 18.70 | 11.99 | 7.27 |
|
研发费用
|
25.66 | 48.22 | 29.46 | 47.31 | 44.94 | 24.68 | 44.35 | 29.82 | 16.30 | 13.18 | 7.57 | 3.71 |
|
销售、一般及行政费用
|
9.60 | 11.89 | 13.34 | 15.37 | 11.28 | 9.99 | 12.15 | 9.88 | 6.19 | 5.52 | 4.41 | 3.56 |
|
其他营业费用
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
营业利润
|
-35.27 | -60.12 | -42.79 | -62.68 | -56.22 | -34.67 | -56.51 | -39.70 | -22.49 | -18.70 | -11.99 | -7.27 |
|
营业外收入
|
1.42 | 4.27 | 5.25 | 0.66 | -1.56 | -1.61 | 0.94 | 0.81 | 0.15 | 0.00 | -0.10 | 2.08 |
|
利息收入
|
3.32 | 6.19 | 7.32 | 2.35 | 0.19 | 0.29 | 1.54 | 0.95 | 0.26 | 0.10 | 0.01 | 0.00 |
|
利息支出
|
- | - | 2.07 | 1.69 | 1.74 | 1.90 | 0.60 | 0.15 | 0.11 | 0.11 | 0.11 | 0.24 |
|
其他营业外收入/支出
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
税前利润
|
- | - | - | - | -57.78 | -38.03 | -62.14 | - | - | - | - | - |
|
所得税费用
|
- | - | - | - | 0.00 | -0.48 | -1.31 | - | - | - | - | - |
|
少数股东损益
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
净利润
|
-33.85 | -55.85 | -37.54 | -62.02 | -57.78 | -37.55 | -60.83 | -38.89 | -22.34 | -18.70 | -12.09 | -5.19 |
补充资料
每股数据、派生项目及其他——不属于利润表
除特别注明外，单位均为百万美元
| 指标 | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
折旧与摊销
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-35.27 | -60.12 | -42.79 | -62.68 | -56.22 | -34.67 | -56.51 | -39.70 | -22.49 | -18.70 | -11.99 | -7.27 |
|
基本每股收益
|
-0.56 | -0.94 | -0.64 | -1.06 | - | - | - | - | - | - | -1.40 | -2.51 |
|
稀释每股收益
|
-0.56 | -0.94 | -0.64 | -1.06 | - | - | - | - | - | - | -1.40 | -3.09 |
|
加权平均股数
|
60.06 | 59.48 | 58.94 | 58.41 | - | - | - | - | - | - | 8.63 | 3.82 |
|
稀释加权平均股数
|
60.06 | 59.48 | 58.94 | 58.41 | - | - | - | - | - | - | 8.63 | 3.85 |
|
综合收益
|
-33.88 | -55.81 | -37.44 | -62.13 | -57.78 | -37.56 | -60.81 | -38.88 | -22.36 | -18.69 | -12.10 | - |